Literature DB >> 11093739

Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome.

V Keitel1, J Kartenbeck, A T Nies, H Spring, M Brom, D Keppler.   

Abstract

The Dubin-Johnson syndrome is an inherited disorder characterized by conjugated hyperbilirubinemia. The deficient hepatobiliary transport of anionic conjugates is caused by the absence of a functional multidrug-resistance protein 2 (MRP2, symbol ABCC2) from the apical (canalicular) membrane of hepatocytes. Mechanisms underlying this deficiency may include rapid degradation of mutated MRP2 messenger RNA (mRNA) or impaired MRP2 protein maturation and trafficking. We investigated the consequences of the mutation MRP2Delta(R,M), which leads to the loss of 2 amino acids from the second ATP-binding domain of MRP2. The MRP2Delta(R,M) mutation is associated with the absence of the MRP2 glycoprotein from the apical membrane of hepatocytes. Transfection of mutated MRP2 complementary DNA (cDNA) led to an MRP2Delta(R,M) protein that was only core glycosylated, sensitive to endoglycosidase H digestion, and located in the endoplasmic reticulum (ER) of transfected HEK293 and HepG2 cells. This indicated that deletion of Arg1392 and Met1393 leads to impaired maturation and trafficking of the protein from the ER to the Golgi complex. Inhibition of proteasome function resulted in a paranuclear accumulation of the MRP2Delta(R,M) protein, suggesting that proteasomes are involved in the degradation of the mutant protein. This is the first mutation in Dubin-Johnson syndrome shown to cause deficient MRP2 maturation and impaired sorting of this glycoprotein to the apical membrane.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093739     DOI: 10.1053/jhep.2000.19791

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

Review 1.  Hepatocellular transport proteins and their role in liver disease.

Authors:  C Stanca; D Jung; P J Meier; G A Kullak-Ublick
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Ultrastructure of Kupffer cells and hepatocytes in the Dubin-Johnson syndrome: a case report.

Authors:  Maria Elzbieta Sobaniec-Lotowska; Dariusz Marek Lebensztejn
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

3.  Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice.

Authors:  Oliver Müller; Carmen Schalla; Jürgen Scheibner; Eduard F Stange; Michael Fuchs
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

4.  CFTR-associated ligand is a negative regulator of Mrp2 expression.

Authors:  Man Li; Carol J Soroka; Kathy Harry; James L Boyer
Journal:  Am J Physiol Cell Physiol       Date:  2016-11-09       Impact factor: 4.249

Review 5.  Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.

Authors:  Kousei Ito; Hiroshi Suzuki; Toshiharu Horie; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 6.  Human pharmacogenomic variations and their implications for antifungal efficacy.

Authors:  Joseph Meletiadis; Stephen Chanock; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

7.  Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant.

Authors:  R Arlanov; T Lang; G Jedlitschky; E Schaeffeler; T Ishikawa; M Schwab; A T Nies
Journal:  Pharmacogenomics J       Date:  2015-04-21       Impact factor: 3.550

8.  Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing.

Authors:  Iñigo Narvaiza; Oscar Aparicio; María Vera; Nerea Razquin; Sergia Bortolanza; Jesús Prieto; Puri Fortes
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

9.  Characterization of polarized expression of point- or deletion-mutated human BCRP/ABCG2 in LLC-PK1 cells.

Authors:  Tappei Takada; Hiroshi Suzuki; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

10.  ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling.

Authors:  Yuji Tanaka; Lauren M Aleksunes; Yue Julia Cui; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2009-01-29       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.